로딩 중…
지수 로딩 중…
Wooree Bio Co.,Ltd
082850· KOSDAQ· Information Technology· Semiconductors & Semiconductor Equipment
₩3,815-2.05%
2026-11-02
Financials
Valuation Metrics
Wooree Bio Co.,Ltd's Market Cap is ₩370B. At end of 2025 it was ₩986B. Ranked #1901 of 2,405 in KR market (top 79%), #1182 of 1,627 on KOSDAQ (top 73%), #180 of 212 in Semiconductors & Semiconductor Equipment (top 85%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 36.97B KRW | KR#1,901/2,405 Sec#180/212 |
| Revenue | 1.10T KRW | KR#385/2,405 Sec#9/212 |
| Net Income | -1.85B KRW | KR—/2,405 Sec—/212 |
| Total Assets | 873.08B KRW | KR#518/2,405 Sec#18/212 |
| Net Assets | 263.32B KRW | KR#791/2,405 Sec#61/212 |
| Employees | 90 | KR#1,716/2,405 Sec#163/212 |
| Value | ||
| P/B | 0.14x | KR#56/2,405 Sec#4/212 |
| P/S | 0.03x | KR#12/2,405 Sec#1/212 |
| FCF Yield | 35.10% | KR#169/2,405 Sec#5/212 |
| Profitability | ||
| ROE | -0.70% | KR#1,598/2,405 Sec#137/212 |
| ROA | -0.21% | KR#1,572/2,405 Sec#136/212 |
| Op. Margin | -0.38% | KR#1,631/2,405 Sec#136/212 |
| Revenue Growth | -5.78% | KR#1,801/2,405 Sec#157/212 |
| Financial Health | ||
| Debt Ratio | 231.57% | KR#2,157/2,405 Sec#201/212 |
| Total Debt | 270.09B KRW | KR#441/2,405 Sec#23/212 |
| FCF | 12.98B KRW | KR#641/2,405 Sec#50/212 |
| Cash | 0 KRW | KR—/2,405 Sec—/212 |
| Current Ratio | 1.15x | KR#1,540/2,405 Sec#146/212 |
| Dividend | ||
| Div. Yield | 2.63% | KR#777/2,405 Sec#23/212 |
| Div. Growth | 0.00% | KR—/2,405 Sec—/212 |
| Performance | ||
| 1Y Return | -63.92% | KR#2,208/2,405 Sec#201/212 |
| 1M Return | -16.15% | KR#1,645/2,405 Sec#84/212 |
| From 52W High | -70.43% | KR#2,065/2,405 Sec#180/212 |
| 1Y MDD | -67.18% | KR#1,814/2,405 Sec#139/212 |
| Trading | ||
| Volume | 19,340 shares | KR#1,507/2,405 Sec#170/212 |
| Trading Value | 74.6M KRW | KR#1,546/2,405 Sec#170/212 |
| Foreign Own. | 2.27% | KR#1,531/2,405 Sec#159/212 |
| Per Share | ||
| EPS | -191 KRW | KR—/2,405 Sec—/212 |
| BPS | 27,170 KRW | KR#411/2,405 Sec#17/212 |
Company Info
동사는 2000년 설립, 2005년 코스닥에 상장되었으며 국내 4개 법인과 중국, 베트남, 미국 등 9개 해외 법인 운영 중임. 건강기능식품, LED PKG, SMT, LED BLU 등의 전자부품을 제조, 판매하며 솔루티오 등 독자 브랜드로 리포좀 공법 적용한 차별화 제품 공급함. FPCB 사업은 신제품 개발, 품질 향상, 원가 경쟁력 강화로 BLU 중심 구조에서 일반산업용 제품으로 확장하고 있음. 우리바이오는 2000년에 설립되었으며 경기도 안산시에 본사를 두고 있습니다.